PE22-28
£69.00
If you are looking for a Certificate Of Analysis, please email research@peptidesuk.co.uk to have it sent to you.
Please Note: Many sites are displaying counterfeit COAs, so ours is provided upon request.
You may also like…
Product Description
PE22-28 is a synthetic analog of spadin, a peptide derived from the sortilin-related receptor (SorCS2) propeptide. It is studied for its potent antidepressant-like effects and neuroprotective properties. PE22-28 modulates TREK-1 potassium channels, which are implicated in mood regulation and neuronal excitability, making it of significant interest in preclinical models of depression and neurological disorders.
Benefits (Based on Preclinical Research)
-
Rapid-acting antidepressant effects in animal models
-
Blocks TREK-1 potassium channels linked to depression
-
Enhances neurogenesis and synaptic plasticity
-
Reduces anxiety and improves stress resilience
-
Studied in mood disorders, cognitive impairment, and neuroinflammation
Who Uses This
Neuroscientists and pharmacology researchers use PE22-28 in studies targeting novel antidepressant mechanisms and exploring neuronal repair strategies.
Why Choose PE22-28
-
Fast-onset neuropeptide targeting mood pathways
-
Supplied sterile and lyophilized for laboratory reconstitution
-
Verified for purity and molecular identity with COA
-
Suitable for CNS, psychiatric, and neurodegeneration models
Documentation and Quality
Each batch is lab-tested and shipped under validated cold-chain protocols. Includes Certificate of Analysis, HPLC, and MS data.
Disclaimer
PE22-28 is intended strictly for research use only. Not approved for human use or therapeutic application. For handling by qualified laboratories and licensed research professionals.
